The spherulitesTM: a promising carrier for oligonucleotide delivery
- 15 August 2000
- journal article
- Published by Oxford University Press (OUP) in Nucleic Acids Research
- Vol. 28 (16) , 3134-3142
- https://doi.org/10.1093/nar/28.16.3134
Abstract
Concentric multilamellar microvesicles, named spherulites(TM), were evaluated as an oligonucleotide carrier. Up to 80% oligonucleotide was encapsulated in these vesicles. The study was carried out on two different spherulite(TM) formulations. The spherulite(TM) size and stability characteristics are presented. Delivery of encapsulated oligonucleotide was performed on a rat hepatocarcinoma and on a lymphoblastoid T cell line, both expressing the luciferase gene. We showed that spherulites(TM) were able to transfect both adherent and suspension cell lines and deliver the oligonucleotide to the nucleus. Moreover, 48-62% luciferase inhibition was obtained in the rat hepatocarcinoma cell line when the antisense oligonucleotide targeted to the luciferase coding region was encapsulated at 500 nM concentration in spherulites(TM) of different compositions.Keywords
This publication has 39 references indexed in Scilit:
- Polyethylenimine but Not Cationic Lipid Improves Antisense Activity of 3′-Capped Phosphodiester OligonucleotidesAntisense and Nucleic Acid Drug Development, 1999
- Delivery of Antisense Oligonucleotides and Plasmid DNA with Various Carrier AgentsAntisense and Nucleic Acid Drug Development, 1999
- Transgene expression, but not gene delivery, is improved by adhesion-assisted lipofection of hematopoietic cellsGene Therapy, 1999
- Intracellular Localization of Oligonucleotides: Influence of Fixative ProtocolsAntisense and Nucleic Acid Drug Development, 1999
- Cationic Lipids Employed for Antisense Oligodeoxynucleotide Transport May Inhibit Vascular Cell Adhesion Molecule-1 Expression in Human Endothelial Cells: A Word of CautionAntisense and Nucleic Acid Drug Development, 1999
- Optimal Lipofection Reagent Varies with the Molecular Modifications of the DNAAntisense and Nucleic Acid Drug Development, 1998
- Development of a Sustained-Release Biodegradable Polymer Delivery System for Site-Specific Delivery of Oligonucleotides: Characterization of P(LA-GA) Copolymer MicrospheresIn VitroJournal of Drug Targeting, 1998
- Characterization of Complexes of Oligonucleotides with Polyamidoamine Starburst Dendrimers and Effects on Intracellular DeliveryJournal of Pharmaceutical Sciences, 1997
- Activation of the Complement System by Synthetic DNA Complexes: A Potential Barrier for Intravenous Gene DeliveryHuman Gene Therapy, 1996
- Functional Analysis of the Rat Insulin-Like Growth Factor I Gene and Identification of an IGF-I Gene PromoterDNA and Cell Biology, 1992